MUMBAI, Aug. 13 -- Eli Lilly has stepped up its fight with Novo Nordisk in India's fast-growing anti-obesity market, launching a prefilled pen version of its blockbuster weight-loss drug Mounjaro at the same price as its injectable vials. The KwikPen, available in six dosage strengths, follows the March launch of Mounjaro in injectable vials, giving Lilly an early-mover advantage in India.

Mounjaro KwikPen is a multi-dose, single-patient-use device, with each pen containing four fixed doses administered once a week. Dosage strengths range from 2.5 mg to 15 mg, with monthly pricing starting at Rs.14,000 for the 2.5 mg dose and going up to Rs.27,500 for the 15 mg dose, Lilly said in a release on Wednesday.

"The launch of Mounjaro KwikPen ...